22nd Century Group, Inc. (NASDAQ:XXII), and its global plant research partner KeyGene achieved a breakthrough in their research leading to the successful transformation of the hemp/cannabis plant genome using proprietary plant transformation, regeneration technology and clear protein expression by the introduced genes.
"I cannot emphasize enough what an enormous achievement it is for our company to have cracked the code to show proof of genome transformation in the hemp/cannabis plant. This is the holy grail in plant science and places us in a commanding leadership position in the race to secure patents and other valuable intellectual property in the emerging hemp/cannabis genetics field," stated James A. Mish, CEO of 22nd Century Group.
